Eton Pharmaceuticals, Inc. (ETON) Operating margin 2019–2025
Eton Pharmaceuticals, Inc. (ETON) operating margin by fiscal year — reported operating income divided by reported revenue.
-1.1%FY2025 · since FY2019: -1939.6% → -1.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1.1% | +5.6 pp |
| FY2024 | -6.7% | -2.9 pp |
| FY2023 | -3.8% | +35.1 pp |
| FY2022 | -38.9% | -32.0 pp |
| FY2021 | -6.8% | +69508.5 pp |
| FY2020 | -69515.4% | -67575.8 pp |
| FY2019 | -1939.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice